Bruker Expects its Fluorotype® SARS-CoV-2 varID Q PCR Assay to Reliably Detect and Tentitavely Differentiate Omicron (B.1.1.529) Variant


Bruker Corporation announced on December 2nd that its established CE-IVD marked FluoroType® SARS-CoV-2 varID Q real-time multiplexed PCR assay reliably detects all SARS-CoV-2 variants, and in addition is expected to also provide a clear indication of Omicron (B.1.1.529), recently declared a ‘variant of concern’ by the WHO. FluoroType® SARS-CoV-2 varID Q is a multiplexed CE-IVD marked PCR assay for the detection and quantification of all major SARS-CoV-2 variants, based on Bruker´s proprietary LiquidArray® technology.

Read more about this news here.

Related articles

Recent articles